7 results match your criteria: "Hebei Province Cangzhou Hospital of Integrated Traditional Chinese Medicine-Western Medicine[Affiliation]"
BMJ Open
December 2024
Department of Intensive Care, Cangzhou Central Hospital, Cangzhou, China
Objective: The supraglottic airway device is a viable alternative to tracheal intubation for elective surgery. To conduct a comparative analysis of the advantages and disadvantages associated with use of the Baska mask and I-gel across various dimensions.
Design: A comprehensive search was conducted across PubMed, Embase, Cochrane Library, Web of Science, and other relevant databases to identify randomised controlled trials (RCTs) involving patients who used the Baska mask and I-gel.
J Asian Nat Prod Res
September 2024
School of Chinese Medicine, Beijing University of Chinese Medicine, Beijing 100029, China.
Acute promyelocytic leukemia (APL) is marked by a block at the promyelocyte stage. Treatments like ATRA and ATO face resistance and relapse issues. , a traditional Chinese medicine, may offer therapeutic potential.
View Article and Find Full Text PDFBMC Musculoskelet Disord
July 2024
Department of Orthopedics, Hebei Province Cangzhou Hospital of Integrated Traditional Chinese Medicine-Western Medicine, Cangzhou, China.
J Robot Surg
May 2024
Department of Orthopaedics, Hebei Province Cangzhou Hospital of Integrated Traditional Chinese Medicine-Western Medicine, Cangzhou, China.
Diabetes Obes Metab
July 2024
Clinical Research and Development, Jiangsu Hengrui Pharmaceuticals Co., Ltd, Shanghai, China.
Aim: To evaluate the efficacy and safety of retagliptin in Chinese patients with type 2 diabetes (T2D) inadequately controlled with metformin.
Materials And Methods: This multicentre, phase 3 trial consisted of a 16-week, randomized, double-blind, placebo-controlled period, where patients with HbA1c levels between 7.5% and 11.
Spine J
February 2024
The Third Hospital of Hebei Medical University, 139 Ziqiang Road, Shijiazhuang, P.R. China, 050035. Electronic address:
Background: Intervertebral disc degeneration (IVDD) is a common degenerative condition, which is thought to be a major cause of lower back pain (LBP). However, the etiology and pathophysiology of IVDD are not yet completely clear.
Purpose: To examine potential causal effects of modifiable risk factors on IVDD.
Front Genet
March 2023
Department of Orthopaedics, Hebei Province Cangzhou Hospital of Integrated Traditional Chinese Medicine-Western Medicine, Cangzhou, China.
Intervertebral disc (IVD) degeneration and its inflammatory microenvironment can result in discogenic pain, which has been shown to stem from the nucleus pulposus (NP). Increasing evidence suggests that mitochondrial related genes are strictly connected to cell functionality and, importantly, it can regulate cell immune activity in response to damaged associated signals. Therefore, identification of mitochondria related genes might offer new diagnostic markers and therapeutic targets for IVD degeneration.
View Article and Find Full Text PDF